Record NNP B-NP O
date NN I-NP O
: : O O
2081-03-17 CD O B-DATE
PICH NNP B-NP B-HOSPITAL
CLINIC NN I-NP O
VISIT NNP I-NP O
PT NNP I-NP O
: : O O
Nora NNP B-NP B-PATIENT
Greenwood NNP I-NP I-PATIENT
Date NNP I-NP O
of IN B-PP O
Visit NNP B-NP O
: : O O
3/17/8 CD B-NP I-DATE
1 CD I-NP I-DATE
ID/CC NNP I-NP O
: : O O
49 CD B-NP B-AGE
F NNP I-NP O
with IN B-PP O
type NN B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
hidranitis NN B-NP O
suppurativa NN I-NP O
, , O O
panic NN B-NP O
attacks NNS I-NP O
, , O O
and CC O O
fibromyalgia VBD B-VP O
presenting VBG I-VP O
to TO I-VP O
PICH VB I-VP B-HOSPITAL
for IN B-PP O
f/u NNS B-NP O
visit VBP B-VP O
re RB O O
: : O O
1 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
, , O O
2 CD B-NP O
) -RRB- I-NP O
hidrantis NN I-NP O
suppurative NN I-NP O
; : O O
3 CD B-NP O
) -RRB- I-NP O
STD NNP I-NP O
testing NN I-NP O
; : O O
4 CD B-NP O
) -RRB- I-NP O
left VBD B-VP O
shoulder NN B-NP O
pain NN I-NP O
and CC O O
to TO B-VP O
sign VB I-VP O
up RP B-PRT O
for IN B-SBAR O
narcotics NNS B-NP O
log VBP B-VP O
. . O O
HPI NNP B-NP O
: : O O
Interval NNP B-NP O
hx VBD B-VP O
to TO I-VP O
be VB I-VP O
reviewed VBN I-VP O
by IN B-PP O
specific JJ B-NP O
issue NN I-NP O
. . O O
1 CD O O
) -RRB- B-NP O
DM NNP I-NP O
: : O O
Most RBS B-NP O
recent JJ I-NP O
HgbA1c NNP I-NP O
2/02/8 CD I-NP I-DATE
1 CD I-NP I-DATE
: : O O
7.4 CD B-NP O
% NN I-NP O
( -LRB- B-PP O
previously RB B-NP O
6.9 CD I-NP O
) -RRB- I-NP O
and CC I-NP O
urine JJ I-NP O
microalb/crt NN I-NP O
: : O O
62.8. DT B-NP O
2/8 CD I-NP I-DATE
1 CD I-NP I-DATE
chem NN I-NP O
7 CD I-NP O
wnl NN I-NP O
( -LRB- I-NP O
na TO B-VP O
: : B-NP O
137 CD I-NP O
, , I-NP O
k NN I-NP O
: : O O
4.1 CD B-NP O
, , O O
BUN/CRT NNP B-NP O
: : O O
15/0.7 CD B-NP O
) -RRB- I-NP O
, , O O
GLU NNP B-NP O
: : O O
186 CD B-NP O
. . O O
AM VBP B-VP O
FS NNS B-NP O
: : O O
109-160 CD B-NP O
; : O O
2 CD B-NP O
hour NN I-NP O
post NN I-NP O
prandial JJ I-NP O
114-115 CD I-NP O
. . O O
~ RBR B-ADVP O
2 CD B-NP O
episodes NNS I-NP O
per IN B-PP O
month NN B-NP O
where WRB B-ADVP O
she PRP B-NP O
feels VBZ B-VP O
lightheaded VBN I-VP O
, , O O
shaky JJ B-NP O
and CC O O
has VBZ B-VP O
to TO I-VP O
eat VB I-VP O
; : O O
has VBZ B-PP O
not RB B-NP O
checked VBN I-NP O
FS NNS I-NP O
at IN B-PP O
time NN B-NP O
of IN B-PP O
episodes NNS B-NP O
; : O O
resolve NN B-NP O
with IN B-PP O
PO NNP B-NP O
intake NN I-NP O
. . O O
Describes NNS B-VP O
frequently RB I-VP O
missing VBG I-VP O
meals NNS B-NP O
; : O O
not RB O O
eating VBG B-VP O
breakfast NN B-NP O
. . O O
Continues '' O O
to TO B-VP O
describe VB I-VP O
increased VBN B-NP O
activity NN I-NP O
level NN I-NP O
. . O O
2 CD B-NP O
) -RRB- I-NP O
Hidranitis NNP I-NP O
suppurativa NN I-NP O
: : O O
Referred VBN B-VP O
to TO B-PP O
general JJ B-NP O
surgeon NN I-NP O
Dr. NNP I-NP O
Iyer NNP I-NP B-DOCTOR
at IN B-PP O
last JJ B-NP O
visit NN I-NP O
. . O O
Nora NNP O B-PATIENT
saw VBD B-VP O
Dr. NNP B-NP O
Iyer NNP I-NP B-DOCTOR
on IN B-PP O
3/02/8 CD B-NP I-DATE
1 CD I-NP I-DATE
who WP B-NP O
felt VBD B-VP O
that IN B-PP O
given VBN B-NP O
the DT B-NP O
broad JJ I-NP O
extent NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
axillary NN I-NP O
involvement NN I-NP O
, , O O
she PRP B-NP O
would MD B-VP O
require VB I-VP O
extensive JJ B-NP O
debridement NN I-NP O
and CC I-NP O
excision NN I-NP O
, , O O
and CC O O
likely JJ B-NP O
flap NN I-NP O
rotation NN I-NP O
coverage NN I-NP O
. . O O
He PRP B-ADVP O
, , O O
therefore RB B-ADVP O
, , O O
referred VBD B-VP O
her PRP$ B-NP O
to TO B-PP O
plastic NN B-NP O
surgery NN I-NP O
. . O O
Feels NNS B-VP O
that IN B-SBAR O
she PRP B-NP O
needs VBZ B-VP O
abx RB B-ADVP O
again RB B-ADVP O
bc IN B-PP O
of IN B-PP O
increasing VBG B-VP O
drainage NN B-NP O
and CC I-NP O
erythema NN I-NP O
. . O O
Cipro NNP B-NP O
has VBZ B-VP O
been VBN I-VP O
most RBS B-ADJP O
helpful JJ I-ADJP O
recently RB B-ADVP O
. . O O
Previously RB B-ADJP O
cultured JJ I-ADJP O
and CC O O
negative JJ B-ADJP O
for IN B-PP O
MRSA NNP B-NP O
. . I-NP O
Today NNP I-NP O
, , O O
denies VBZ B-VP O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
ns NNS B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
increasing VBG B-VP O
pain NN B-NP O
. . O O
3 CD B-NP O
) -RRB- I-NP O
STD NNP I-NP O
testing NN I-NP O
: : O O
Nora NNP B-NP B-PATIENT
recently RB B-ADVP O
reported VBD B-VP O
that IN O O
her PRP$ B-NP O
ex NN I-NP O
husband NN I-NP O
had VBD B-VP O
told VBN I-VP O
her PRP B-NP O
that IN B-SBAR O
he PRP B-NP O
had VBD B-VP O
HCV RB B-ADJP O
while IN B-SBAR O
they PRP B-NP O
were VBD B-VP O
together RB B-ADVP O
but CC O O
never RB B-VP O
told VBD I-VP O
her PRP B-NP O
. . B-NP O
11/8 CD I-NP I-DATE
0 CD I-NP I-DATE
HCV NNP I-NP O
ab NN I-NP O
negative JJ I-NP O
. . O O
Completed NNP B-NP O
further RB B-ADVP O
STD VBD B-VP O
testing VBG I-VP O
at IN B-PP O
last JJ B-NP O
visit NN I-NP O
and CC O O
HbsAg NNP B-NP O
, , O O
HBsAb NNP B-NP O
, , O O
TA-IGG NNP B-NP O
, , O O
and CC O O
HIV NNP B-NP O
were VBD B-VP O
negative JJ B-ADJP O
. . O O
Still RB O O
have VBP B-VP O
not RB I-VP O
been VBN I-VP O
able JJ B-ADJP O
to TO B-VP O
check VB I-VP O
GC NNP B-NP O
and CC I-NP O
Chlamydia NNP I-NP O
bc , O O
Nora NNP B-NP B-PATIENT
feels VBZ B-VP O
she PRP B-NP O
can MD B-VP O
not RB I-VP O
undergo VB I-VP O
pelvic JJ B-NP O
exam NN I-NP O
given VBN B-VP O
HS NNP B-NP O
in IN B-PP O
groin NN B-NP O
area NN I-NP O
. . B-VP O
Denies NNS B-NP O
any DT B-NP O
vaginal JJ I-NP O
discharge NN I-NP O
. . O O
Not RB O O
currently RB B-ADVP O
sexually RB B-ADJP O
active JJ I-ADJP O
. . O O
4 CD B-NP O
) -RRB- I-NP O
Shoulder/Arm JJ I-NP O
pain NN I-NP O
: : O O
See VB B-VP O
note NN B-NP O
from IN B-PP O
2/02/8 CD B-NP I-DATE
1 CD I-NP I-DATE
for IN B-PP O
full JJ B-NP O
hx NN I-NP O
details NNS I-NP O
. . O O
Had VBD B-VP O
MRI NNP B-NP O
scheduled VBN B-VP O
for IN B-PP O
2/9/8 CD B-NP I-DATE
1 CD I-NP I-DATE
but CC O O
unable JJ B-ADJP O
to TO B-VP O
go VB I-VP O
through IN B-PP O
2/2 CD B-NP O
claustrophobia NN I-NP O
. . O O
Rescheduled VBN B-VP O
for IN B-PP O
open JJ B-NP O
MRI NNP I-NP O
on IN B-PP O
2/28/8 CD B-NP I-DATE
1 CD I-NP I-DATE
which WDT B-NP O
she PRP B-NP O
was VBD B-VP O
able JJ B-ADJP O
to TO B-VP O
complete VB I-VP O
. . B-NP O
Have VBP B-VP O
not RB I-VP O
yet RB I-VP O
received VBN I-VP O
fax NN B-NP O
of IN B-PP O
results NNS B-NP O
. . O O
5 CD B-NP O
) -RRB- I-NP O
Pain NNP I-NP O
management NN I-NP O
/ NN I-NP O
Narcotics NNP I-NP O
log VBP I-NP O
: : O O
Because IN B-PP O
of IN I-PP O
pain NN B-NP O
2/2 CD I-NP O
severe JJ I-NP O
HS NNP I-NP O
and CC O O
now RB B-ADVP O
L NNP B-NP O
shoulder NN I-NP O
, , O O
Nora NNP B-NP B-PATIENT
has VBZ B-VP O
been VBN I-VP O
taking VBG I-VP O
percocet NN B-NP O
5/325 IN B-PP O
q NNP B-NP O
4 CD I-NP O
hours NNS I-NP O
. . O O
Reviewed VBN B-VP O
policy NN B-NP O
for IN B-PP O
narcotics NNS B-NP O
log VBP B-VP O
. . B-NP O
Reviewed VBN I-NP O
risks NNS I-NP O
and CC I-NP O
benefits NNS I-NP O
of IN B-PP O
narcotic JJ B-NP O
use NN I-NP O
, , O O
including VBG B-PP O
addiction NN B-NP O
. . O O
Describes NNS B-VP O
regular JJ B-NP O
BM NNP I-NP O
s VBZ B-VP O
and CC I-VP O
no DT B-NP O
problems NNS I-NP O
with IN B-PP O
constipation NN B-NP O
in IN B-PP O
spite NN B-NP O
of IN B-PP O
daily JJ B-NP O
narcotics NNS I-NP O
. . O O
Problems NNS B-VP O
Type . B-NP O
2 CD I-NP O
diabetes NN I-NP O
Hyperlipidemia NNP I-NP O
h/o VBD B-VP O
childhood NN B-NP O
asthma NN I-NP O
H/O NNP I-NP O
pyelonephritis NN I-NP O
smoker NN I-NP O
Hypertension NNP I-NP O
Obesity NNP I-NP O
H/O NNP I-NP O
hidradenitis NN I-NP O
suppuritiva NN I-NP O
FH NNP I-NP O
Ovarian NNP I-NP O
cancer NN I-NP O
Comments NNS I-NP O
: : O O
mother NN B-NP O
, , I-NP O
grandmother NN I-NP O
, , O O
and CC O O
sister NN B-NP O
Medications NNS B-NP O
Miconazole NNP I-NP O
CREAM NNP I-NP O
2 CD I-NP O
% NN I-NP O
TOPICAL NN I-NP O
( -LRB- I-NP O
MICONAZOLE NNP I-NP O
NITRATE NNP I-NP O
2 CD I-NP O
% NN I-NP O
) -RRB- O O
1 CD B-NP O
APPLICATION NN I-NP O
( -LRB- I-NP O
2 CD I-NP O
% NN I-NP O
CREAM(GM NN I-NP O
) -RRB- B-PP O
) -RRB- B-NP O
TOP NNP I-NP O
TID NNP I-NP O
Nystatin NNP I-NP O
POWDER NNP I-NP O
TOPICAL NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
x NN I-NP O
21 CD B-NP O
days NNS I-NP O
, , O O
please VB B-VP O
apply VB I-VP O
twice RB B-ADVP O
a DT B-NP O
day NN I-NP O
to TO B-PP O
affected VBN B-NP O
areas NNS I-NP O
Bactrim NN I-NP O
DS NNPS I-NP O
( -LRB- B-VP O
TRIMETHOPRIM NNP B-NP O
/SULFAMETHOXAZOLE NNP I-NP O
DOUBLE NNP I-NP O
STRENGTH) NNP I-NP O
1 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
Augmentin IN B-PP O
875/125 CD B-NP O
( -LRB- I-NP O
AMOXICILLIN/CLAV.ACID JJ I-NP O
875/125 CD I-NP O
) -RRB- I-NP O
875 CD I-NP O
MG NNP I-NP O
(875-125MG JJ I-NP O
TABLET NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP I-NP O
x NN I-NP O
14 CD B-NP O
days NNS I-NP O
Metformin NNP B-NP O
1000 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
500MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
2 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
, , O O
start VB B-VP O
with IN B-PP O
500mg CD B-NP O
1 CD I-NP O
tab NN I-NP O
2x CD I-NP O
per IN B-PP O
day NN B-NP O
; : O O
call NN B-NP O
to TO B-VP O
discuss VB I-VP O
increase NN B-NP O
in IN B-PP O
1 CD B-NP O
wk NN I-NP O
Hydrochlorothiazide NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
25MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
Nizoral JJ B-NP O
(KETOCONAZOLE NN I-NP O
) -RRB- I-NP O
2 CD I-NP O
CREAM NNP I-NP O
( -LRB- I-NP O
2 CD I-NP O
% NN I-NP O
CREAM(GM NN I-NP O
) -RRB- I-NP O
) -RRB- I-NP O
TOP NNP I-NP O
BID NNP I-NP O
, , O O
Apply RB B-ADVP O
to TO B-PP O
affected VBN B-NP O
areas NNS I-NP O
twice RB B-NP O
a DT I-NP O
day NN I-NP O
. . O O
Zocor NNP O O
( -LRB- O O
SIMVASTATIN NNP B-NP O
) -RRB- I-NP O
80 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
80MG NN I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QHS NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
, , O O
if IN B-SBAR O
you PRP B-NP O
develop VBP B-VP O
muscle NN B-NP O
pain NN I-NP O
or CC I-NP O
weakness NN I-NP O
, , O O
stop VB B-VP O
the DT B-NP O
drug NN I-NP O
immediately RB B-ADVP O
and CC O O
call VB B-VP O
your PRP$ B-NP O
doctor NN I-NP O
. . O O
Glucotrol JJ B-NP O
XL NNP I-NP O
( -LRB- I-NP O
GLIPIZIDE NN I-NP O
XL NNP I-NP O
) -RRB- I-NP O
2.5 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
2.5MG JJ I-NP O
TAB NN I-NP O
SR NN I-NP O
OSM NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NN I-NP O
Keflex NNP I-NP O
( -LRB- I-NP O
CEPHALEXIN NN I-NP O
) -RRB- I-NP O
500MG . I-NP O
TABLET NNP I-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QID NNP I-NP O
x NNP I-NP O
14 CD I-NP O
days NNS I-NP O
Levaquin NNP B-NP O
( -LRB- I-NP O
LEVOFLOXACIN NN I-NP O
) -RRB- I-NP O
500 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
500MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
14 CD I-NP O
days NNS I-NP O
Cipro NNP B-NP O
( -LRB- I-NP O
CIPROFLOXACIN NNP I-NP O
) -RRB- I-NP O
500 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
500MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
14 CD I-NP O
days NNS I-NP O
Clindamycin NNP B-NP O
1 CD I-NP O
% NN I-NP O
GEL NNP I-NP O
TOPICAL NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
x NN I-NP O
21 CD B-NP O
days NNS I-NP O
, , O O
please VB B-VP O
apply VB I-VP O
to TO B-PP O
affected VBN B-NP O
areas NNS I-NP O
twice RB B-NP O
a DT I-NP O
day NN I-NP O
Phisohex NNP I-NP O
( -LRB- I-NP O
HEXACHLOROPHENE NNP I-NP O
3 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
5 CD I-NP O
ML NNP I-NP O
TOP NNP I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
Lisinopril NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
40MG JJ I-NP O
TABLET NN I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
Percocet NNP B-NP O
( -LRB- I-NP O
OXYCODONE+APAP NNP I-NP O
) -RRB- I-NP O
5-325MG JJ I-NP O
TABLET NNP I-NP O
PO NNP I-NP O
q4h IN B-PP O
PRN NNP B-NP O
pain NN I-NP O
x NN I-NP O
30 CD B-NP O
days NNS I-NP O
, , O O
do VBP B-VP O
not RB I-VP O
drive VB I-VP O
ot RB I-VP O
operate VB I-VP O
heavy JJ B-NP O
machinery NN I-NP O
while IN B-ADVP O
on IN B-PP O
med JJ B-NP O
as IN I-NP O
can MD B-VP O
make VB I-VP O
you PRP B-NP O
drowsy VB B-VP O
Ativan NNP B-NP O
( -LRB- I-NP O
LORAZEPAM NN I-NP O
) -RRB- I-NP O
0.5 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
0.5MG NN I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP I-NP O
PRN NNP I-NP O
anxiety/panic NN I-NP O
, , O O
take VB B-VP O
one CD B-NP O
tablet NN I-NP O
twice RB B-ADVP O
daily RB I-ADVP O
as IN B-SBAR O
needed VBN B-VP O
for IN B-PP O
panic NN B-NP O
attacks NNS I-NP O
Allergies NNP B-NP O
Erythromycins NNP I-NP O
- : O O
Hives NNS B-NP O
, , I-NP O
PE NN I-NP O
: : O O
Vital JJ B-NP O
Signs NNS I-NP O
BP NNP B-NP O
164/64 CD I-NP O
, , O O
P NNP B-NP O
82 CD I-NP O
, , O O
Wt NNP B-NP O
216 CD I-NP O
lb NN I-NP O
General NNP B-NP O
: : O O
obese NN B-NP O
F NN I-NP O
, , O O
appearing VBG B-VP O
uncomfortable JJ B-NP O
w JJ I-NP O
movement NN I-NP O
of IN B-PP O
shoulder NN B-NP O
HEENT NNP B-NP O
: : O O
anicteric JJ B-NP O
, , I-NP O
mmm JJ I-NP O
, , O O
no DT B-NP O
JVD NN I-NP O
PULM NNP B-NP O
: : O O
CTAB NNP B-VP O
with IN B-PP O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
COR JJ B-NP O
: : O O
rrr NN B-NP O
, , I-NP O
nlS1S2 NN I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
ABD NNP B-NP O
: : O O
obese NN B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
NTND NNP I-NP O
, , I-NP O
+BS NNP I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
appreciated VBN I-NP O
EXT NNP B-NP O
: : O O
no DT B-NP O
LE JJ I-NP O
edema NN I-NP O
, , O O
L NNP B-NP O
shoulder NN I-NP O
w VBD B-VP O
restricted VBN I-VP O
ROM NNP B-NP O
2/2 CD B-NP O
pain NN I-NP O
; : O O
+ NN B-NP O
increased VBD B-VP O
erythema NN B-NP O
and CC O O
mild JJ B-NP O
drainage NN I-NP O
from IN B-PP O
L NNP B-NP O
axilla NN I-NP O
A/P NNP B-NP O
: : O O
49 CD B-NP B-AGE
F NNP I-NP O
with IN B-PP O
type NN B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
hidranitis NN B-NP O
suppurativa NN I-NP O
, , O O
panic NN B-NP O
attacks NNS I-NP O
, , O O
and CC O O
fibromyalgia NN B-NP O
; : O O
a/p NN B-NP O
to TO B-VP O
be VB I-VP O
discussed VBN I-VP O
by IN B-PP O
specific JJ B-NP O
issue NN I-NP O
. . O O
1 CD O O
) -RRB- B-NP O
DM NNP I-NP O
: : O O
Most RBS B-NP O
recent JJ I-NP O
HgbA1c NNP I-NP O
slightly RB B-ADVP O
above IN B-PP O
goal NN B-NP O
of IN B-PP O
<7 NNS B-NP O
( -LRB- O O
7.4 CD B-NP O
) -RRB- I-NP O
and CC O O
increased VBD B-VP O
from IN B-PP O
prior JJ B-NP O
HgbA1c JJ I-NP O
6.9 CD I-NP O
. . O O
Suspect NNP B-NP O
increased VBD B-VP O
HgbA1c PRP B-NP O
reflects VBZ B-VP O
recent JJ B-NP O
cessation NN I-NP O
of IN B-PP O
metformin NN B-NP O
which WDT B-NP O
Nora NNP B-NP B-PATIENT
was VBD B-VP O
not RB O O
able JJ B-ADJP O
to TO B-VP O
tolerate VB I-VP O
. . B-NP O
Per IN B-PP O
her PRP$ B-NP O
report NN I-NP O
, , O O
fasting VBG B-VP O
AM VBP B-NP O
FS NNS I-NP O
appears VBZ B-VP O
most RBS B-ADJP O
elevated JJ I-ADJP O
, , O O
although IN B-PP O
random JJ B-NP O
BG NNP I-NP O
checked VBD B-VP O
at IN B-PP O
last JJ B-NP O
was VBD I-NP O
186 CD I-NP O
. . O O
Asked VBD B-VP O
Nora NNP B-NP B-PATIENT
to TO B-VP O
keep VB I-VP O
a DT B-NP O
log NN I-NP O
of IN B-PP O
her PRP$ B-NP O
FS NNS I-NP O
, , O O
checking VBG B-VP O
fasting NN B-NP O
, , O O
2 CD B-NP O
hour NN I-NP O
post-prandials NNS I-NP O
, , O O
and CC O O
qhs NNS B-NP O
FS NNS I-NP O
on IN B-PP O
alternating NN B-NP O
days NNS I-NP O
. . O O
----increasing JJ B-NP O
Glucotrol NNP I-NP O
XL NNP I-NP O
2.5 CD I-NP O
mg NN I-NP O
qd NN I-NP O
to TO B-PP O
5mg CD B-NP O
qd NN I-NP O
and CC O O
suggested VBD B-VP O
taking VBG I-VP O
at IN B-PP O
night NN B-NP O
given VBN I-NP O
elevated VBD B-VP O
fasting VBG I-VP O
FS NNS B-NP O
, , O O
skipped VBD B-VP O
breakfast NN B-NP O
but CC O O
larger JJR B-NP O
dinner NN I-NP O
, , O O
and CC O O
daytime JJ B-NP O
episodes NNS I-NP O
of IN B-PP O
presumed VBN B-NP O
hypoglycemia NN I-NP O
. . O O
----once NN B-NP O
again RB B-ADVP O
reviewed VBN B-VP O
the DT B-NP O
importance NN I-NP O
of IN B-PP O
regular JJ B-NP O
, , I-NP O
small JJ I-NP O
meals NNS I-NP O
given VBN B-NP O
glucotrol NN I-NP O
; : O O
discussed VBN B-NP O
considering VBG I-NP O
switch NN I-NP O
to TO B-PP O
short-acting JJ B-NP O
glucotrol NN I-NP O
Nora NNP B-NP B-PATIENT
s VBZ B-VP O
slightly RB B-NP O
irregular JJ I-NP O
food NN I-NP O
intake NN I-NP O
to TO B-VP O
avoid VB I-VP O
hypoglycemic JJ B-NP O
episodes NNS I-NP O
. . O O
Will NNP O O
consider VBP B-VP O
switch VB I-VP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
and CC O O
with IN B-PP O
review NN B-NP O
of IN B-PP O
FS NNS B-NP O
log VBP B-VP O
. . O O
----Asked JJ B-NP O
nora NN I-NP B-PATIENT
to TO B-VP O
check VB I-VP O
FS NNS B-NP O
during IN B-PP O
episodes NNS B-NP O
of IN B-PP O
shakiness NN B-NP O
; : O O
will MD B-VP O
need VB I-VP O
to TO I-VP O
monitor VB I-VP O
closely RB B-NP O
given VBN I-NP O
recent JJ I-NP O
start NN I-NP O
of IN B-PP O
BB NNP B-NP O
and CC I-NP O
concern NN I-NP O
that IN B-SBAR O
it PRP B-NP O
may MD B-VP O
mask VB I-VP O
sx VBN I-VP O
s PRP B-NP O
. . O O
Discussed CC O O
this DT B-NP O
w NN I-NP O
Nora NNP B-NP B-PATIENT
and CC O O
once RB B-ADVP O
again RB B-ADVP O
emphasized VBD B-VP O
importance NN B-NP O
of IN B-PP O
regular JJ B-NP O
meals NNS I-NP O
on IN B-PP O
glucotrol NN B-NP O
. . O O
----continue JJ B-NP O
ASA NNP I-NP O
81mg CD I-NP O
qd NN I-NP O
, , O O
lisinopril JJ B-NP O
40mg JJ I-NP O
qd NN I-NP O
---- : O O
2/8 CD B-NP I-DATE
1 CD I-NP I-DATE
urine NN I-NP O
microalb/crt NN I-NP O
: : O O
62.8 CD B-NP O
, , O O
above JJ B-NP O
goal NN I-NP O
of IN B-PP O
<30 CD B-NP O
and CC O O
likely JJ B-NP O
due JJ I-NP O
to TO B-PP O
persistently RB B-NP O
elevated JJ I-NP O
BP. NNP I-NP O
Adding VBG B-VP O
additional JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
agent NN I-NP O
today NN I-NP O
( -LRB- O O
toprol JJ B-NP O
XL NNP I-NP O
) -RRB- I-NP O
and CC O O
will MD B-VP O
re-check VB I-VP O
malb/crt NN B-NP O
once RB B-ADVP O
BP NNP B-NP O
under IN B-PP O
better JJR B-NP O
control NN I-NP O
. . O O
2/8 CD O I-DATE
1 CD B-NP I-DATE
BUN/CRT NNP I-NP O
: : O O
15/0.7. . O O
----will NN B-NP O
perform VBP B-VP O
DM JJ B-NP O
foot NN I-NP O
exam NN I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
. . O O
Nora NNP B-NP B-PATIENT
denies VBZ B-VP O
any DT B-NP O
numbness NN I-NP O
or CC I-NP O
tingling NN I-NP O
of IN B-PP O
extremities NNS B-NP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
. . O O
----BP NNP B-NP O
still RB B-ADVP O
not RB B-ADVP O
at IN B-PP O
DM NNP B-NP O
goal NN I-NP O
of IN B-PP O
<130/8 CD B-NP O
0 CD I-NP O
; : O O
adding VBG B-VP O
Toprol NNP B-NP O
Xl NNP I-NP O
25mg CD I-NP O
qd NN I-NP O
to TO B-PP O
HCTZ NNP B-NP O
25 CD I-NP O
qd NN I-NP O
and CC O O
Lisinopril NNP B-NP O
40 CD I-NP O
qd NN I-NP O
---- : O O
11/8 CD B-NP I-DATE
0 CD I-NP I-DATE
( -LRB- I-NP O
NON-FASTING NN I-NP O
) -RRB- I-NP O
: : O O
TCHOL NN B-NP O
: : O O
189 CD B-NP O
; : O O
HDL NNP B-NP O
: : O O
48 CD B-NP O
, , O O
TRIG NNP B-NP O
: : O O
154 CD B-NP O
, , O O
LDL NNP B-NP O
: : O O
110 CD B-NP O
; : O O
on IN B-PP O
Simvastatin NNP B-NP O
80mg CD I-NP O
qhs NNS I-NP O
. . O O
LDL NNP O O
slightly RB B-ADVP O
above IN B-PP O
DM NNP B-NP O
goal NN I-NP O
of IN B-PP O
<100 CD B-NP O
, , O O
but CC O O
Nora NNP B-NP B-PATIENT
has VBZ B-VP O
since RB I-VP O
attempted VBN I-VP O
to TO I-VP O
increase VB I-VP O
exercise NN B-NP O
and CC O O
eat VB B-VP O
low JJ B-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
diet NN I-NP O
. . O O
Rechecking VBG B-VP O
lipid JJ B-NP O
panel NN I-NP O
today NN B-NP O
. . O O
----OPTHO NN B-NP O
: : O O
will MD B-VP O
need VB I-VP O
to TO I-VP O
confirm VB I-VP O
appt NN B-NP O
at IN B-PP O
f/u DT B-NP O
visit NN I-NP O
2 CD I-NP O
) -RRB- I-NP O
Hidranitis NNP I-NP O
suppurativa NN I-NP O
: : O O
----will NN B-NP O
confirm VBP B-VP O
referral NN B-NP O
to TO B-PP O
plastics NNS B-NP O
and CC O O
schedule NN B-NP O
if IN B-LST O
necessary JJ O O
----prescribing JJ B-NP O
course NN I-NP O
of IN B-PP O
cipro NN B-NP O
given VBN I-NP O
e/o NN I-NP O
inflammation NN I-NP O
( -LRB- B-VP O
less JJR B-ADJP O
than IN B-PP O
previous JJ B-NP O
flares NNS I-NP O
) -RRB- B-VP O
on IN B-PP O
exam NN B-NP O
today NN B-NP O
. . O O
3 CD O O
) -RRB- B-NP O
STD NNP I-NP O
testing NN I-NP O
: : O O
Recent JJ B-NP O
rpr NN I-NP O
, , O O
HIV NNP B-NP O
, , O O
HBC NNP B-NP O
, , O O
and CC O O
HCV NNP B-NP O
neg NN I-NP O
. . B-VP O
Still RB B-ADVP O
not RB O O
able JJ B-ADJP O
to TO B-VP O
test VB I-VP O
for IN B-PP O
GC/Chlamydia NNP B-NP O
, , O O
but CC O O
no DT B-NP O
sx NN I-NP O
s VBZ B-VP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
to TO B-VP O
suggest VB I-VP O
infection NN B-NP O
. . O O
Will MD B-VP O
continue VB I-VP O
to TO I-VP O
offer VB I-VP O
, , O O
but CC O O
again RB B-ADVP O
Nora NNP B-NP B-PATIENT
declined VBD B-VP O
given VBN I-VP O
significant JJ B-NP O
groin NN I-NP O
HS. . O O
----recommended JJ B-NP O
HBV NNP I-NP O
vaccination NN I-NP O
and CC O O
gave VBD B-VP O
Nora NNP B-NP B-PATIENT
green JJ I-NP O
slip4 NNS I-NP O
) -RRB- O O
Left VBD B-VP O
Shoulder/Arm VBN B-NP O
pain NN I-NP O
: : O O
Suspect NN B-NP O
multifactorial JJ I-NP O
2/2 CD I-NP O
possible JJ I-NP O
rotator NN I-NP O
cuff NN I-NP O
injury NN I-NP O
, , O O
biceps NNS B-NP O
tendonitis NN I-NP O
, , O O
and CC O O
adhesive JJ B-NP O
capsilitis NN I-NP O
. . O O
Offered VBN B-VP O
steroid NN B-NP O
inject NN I-NP O
at IN B-PP O
last JJ B-NP O
visit NN I-NP O
, , O O
but CC O O
Nora NNP B-NP B-PATIENT
declined VBD B-VP O
and CC O O
continues VBZ B-VP O
to TO I-VP O
decline VB I-VP O
. . O O
----will JJ B-NP O
call NN I-NP O
about IN B-PP O
MRI NNP B-NP O
results NNS I-NP O
and CC O O
consider VB B-VP O
treatment NN B-NP O
pnd NN I-NP O
results NNS I-NP O
5 CD O O
) -RRB- O O
Pain NNP B-NP O
control/Narcotics NNS I-NP O
log VBP B-VP O
: : O O
Given VBN B-VP O
increased VBN B-NP O
use NN I-NP O
of IN B-PP O
short-acting JJ B-NP O
percocet NN I-NP O
, , O O
started VBD B-VP O
long-acting JJ B-NP O
MS NNP I-NP O
contin NN I-NP O
15mg IN B-PP O
BID NNP B-NP O
and CC O O
encouraged VBD B-VP O
use NN B-NP O
of IN B-PP O
percocet NN B-NP O
for IN B-PP O
break-through JJ B-NP O
pain NN I-NP O
. . O O
No DT B-NP O
trouble NN I-NP O
w VBD B-VP O
constipation NN B-NP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
, , O O
but CC O O
warned VBD B-VP O
Nora NNP B-NP B-PATIENT
of IN B-PP O
increased VBN B-NP O
risk NN I-NP O
given VBN B-VP O
daily JJ B-NP O
use NN I-NP O
of IN B-PP O
narcotics NNS B-NP O
and CC O O
encouraged JJ B-NP O
hydration NN I-NP O
and CC O O
increased VBD B-NP O
fiber NN I-NP O
intake NN I-NP O
. . O O
Also RB B-VP O
reviewed VBN I-VP O
Narcotic JJ B-NP O
log NN I-NP O
contract NN I-NP O
and CC I-NP O
conditions NNS I-NP O
. . O O
Nora NNP B-NP B-PATIENT
is VBZ B-VP O
aware JJ B-ADJP O
of IN B-PP O
conditions NNS B-NP O
and CC I-NP O
rules NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
risks/benefits NNS B-NP O
of IN B-PP O
chronic JJ B-NP O
narcotic JJ I-NP O
treatment NN I-NP O
. . O O
She PRP B-NP O
agreed VBD B-VP O
to TO B-PP O
drug NN B-NP O
testing NN I-NP O
today NN B-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
all DT B-NP O
conditions NNS I-NP O
described VBD B-VP O
in IN B-PP O
contract NN B-NP O
. . O O
----checking JJ B-NP O
urine JJ I-NP O
drug NN I-NP O
test NN I-NP O
today NN B-NP O
( -LRB- O O
Nora NNP B-NP B-PATIENT
affirmed VBD B-VP O
use NN B-NP O
of IN B-PP O
valium NN B-NP O
and CC I-NP O
percocet NN I-NP O
at IN B-PP O
6:00am NN B-NP O
) -RRB- I-NP O
6 CD I-NP O
) -RRB- I-NP O
HTN NNP I-NP O
: : O O
Still RB B-ADVP O
above IN B-PP O
goal NN B-NP O
of IN B-PP O
<130/8 CD B-NP O
0 CD I-NP O
and CC B-PP O
with IN B-PP O
e/o JJ B-NP O
microablumin NN I-NP O
on IN B-PP O
2/8 CD B-NP I-DATE
1 CD I-NP I-DATE
urine JJ I-NP O
test NN I-NP O
on IN B-PP O
HCTZ NNP B-NP O
25mg CD I-NP O
qd NN I-NP O
and CC I-NP O
lisinopril NN I-NP O
40mg JJ I-NP O
qd NN I-NP O
. . O O
Will MD B-VP O
add VB I-VP O
toprol JJ B-NP O
XL NNP I-NP O
25mg CD I-NP O
qd NN I-NP O
today NN B-NP O
. . O O
Discussed VBN B-VP O
possible JJ B-NP O
side-effects NNS I-NP O
including VBG I-NP O
fatigue NN I-NP O
, , O O
mood NN B-NP O
changes NNS I-NP O
, , O O
etc FW B-NP O
. . O O
----scheduled JJ B-NP O
f/u NN I-NP O
with IN B-PP O
NP NNP B-NP O
in IN B-PP O
10d CD B-NP O
to TO B-VP O
re-check VB I-VP O
BP NNP B-NP O
and CC I-NP O
HR NNP I-NP O
; : O O
consider VB B-VP O
increasing VBG B-NP O
dose NN I-NP O
if IN B-PP O
still RB B-ADVP O
not RB I-ADVP O
at IN B-PP O
goal NN B-NP O
and CC O O
HR NNP B-NP O
tolerates NNS I-NP O
. . O O
Will NNP B-NP O
also RB B-ADVP O
assess VBP B-VP O
for IN B-PP O
development NN B-NP O
of IN B-PP O
any DT B-NP O
SE NNP I-NP O
at IN B-PP O
that DT B-NP O
visit NN I-NP O
. . O O
----TO NNP B-NP O
DO VB I-NP O
: : O O
review VB B-VP O
sleep NN B-NP O
apnea NN I-NP O
ROS NNP B-VP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
and CC O O
will MD B-VP O
need VB I-VP O
to TO I-VP O
re-visit VB I-VP O
smoking NN B-NP O
cessation NN I-NP O
7 CD B-NP O
) -RRB- I-NP O
Elevated VBN I-NP O
AP NNP I-NP O
: : O O
Suspect NNP B-NP O
2/2 CD I-NP O
fatty NN I-NP O
liver NN I-NP O
(elevated VBD B-VP O
GGT NNP B-NP O
confirming VBG I-NP O
GI NNP I-NP O
source NN I-NP O
and CC O O
RUQ NNP B-NP O
w VBD B-VP O
e/o RB B-NP O
fatty JJ I-NP O
liver NN I-NP O
) -RRB- I-NP O
and CC O O
asx RB B-ADVP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
; : O O
continue VB B-VP O
RF NN B-NP O
modification NN I-NP O
( -LRB- I-NP O
wt JJ I-NP O
loss NN I-NP O
, , O O
strict JJ B-NP O
lipid JJ I-NP O
control NN I-NP O
) -RRB- O O
. . B-NP O
Will NNP I-NP O
re-check NN I-NP O
in IN B-PP O
6 CD B-NP O
mos NN I-NP O
( -LRB- I-NP O
~ NN I-NP O
7-8/8 CD I-NP I-DATE
1 CD I-NP I-DATE
) -RRB- I-NP O
. . O O
Consider VB B-VP O
GI CC I-VP O
eval VB I-VP O
if IN B-PP O
significant JJ B-NP O
elevation NN I-NP O
or CC I-NP O
symptoms NNS I-NP O
. . O O
8 CD B-NP O
) -RRB- I-NP O
Panic NN I-NP O
attacks NNS I-NP O
: : O O
continue VB B-VP O
tx NN B-NP O
through IN B-PP O
psych NN B-NP O
( -LRB- I-NP O
CBT NNP I-NP O
and CC I-NP O
valium JJ I-NP O
prn NN I-NP O
) -RRB- I-NP O
. . O O
----confirm JJ B-NP O
f/u NN I-NP O
appt NN I-NP O
w VBD B-VP O
psych NN B-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
9 CD B-NP O
) -RRB- I-NP O
+FH . O O
of IN B-PP O
ovarian JJ B-NP O
cancer NN I-NP O
( -LRB- I-NP O
mother NN I-NP O
, , O O
sister NN B-NP O
, , O O
maternal JJ B-NP O
GM NNP I-NP O
died VBD B-VP O
of IN B-PP O
ovarian JJ B-NP O
CA NNP I-NP O
) -RRB- I-NP O
. . O O
Has NNP B-NP O
had VBD B-VP O
multiple JJ B-NP O
previously RB I-NP O
scheduled VBN I-NP O
appts NNS I-NP O
to TO B-VP O
see VB I-VP O
high JJ B-NP O
risk NN I-NP O
clinic NN I-NP O
at IN B-PP O
MTCI NNP B-NP B-HOSPITAL
. . O O
Again RB B-VP O
offered VBD I-VP O
to TO I-VP O
re-schedule VB I-VP O
for IN B-PP O
her PRP B-NP O
, , O O
but CC O O
Nora NNP B-NP B-PATIENT
said VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
the DT B-NP O
number NN I-NP O
and CC O O
was VBD B-VP O
going VBG I-VP O
to TO I-VP O
reschedule VB I-VP O
. . O O
Asked VBD B-VP O
her PRP$ I-VP O
to TO I-VP O
call VB I-VP O
me PRP B-NP O
with IN B-PP O
date NN B-NP O
to TO B-VP O
confirm VB I-VP O
. . O O
10 CD B-NP O
) -RRB- I-NP O
TOBACCO NNP I-NP O
USE NNP I-NP O
: : O O
Nora NNP B-NP B-PATIENT
reported VBD B-VP O
quitting VBG I-VP O
at IN B-PP O
last JJ B-NP O
visit NN I-NP O
but CC I-NP O
today NN I-NP O
smelled VBD B-VP O
of IN B-PP O
smoke NN B-NP O
. . O O
Confirmed NNP O O
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
restarted VBN I-VP O
, , O O
~ RB B-ADVP O
4 CD B-NP O
cig/day NN I-NP O
. . O O
Will MD B-VP O
need VB I-VP O
to TO I-VP O
discuss VB I-VP O
further JJ B-ADVP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
and CC O O
once RB B-VP O
again RB I-VP O
review VB I-VP O
crucial JJ B-NP O
nature NN I-NP O
of IN B-PP O
smoking NN B-NP O
cessation NN I-NP O
for IN B-PP O
her PRP B-NP O
. . O O
11 CD B-NP O
) -RRB- I-NP O
HCM . O O
---- : O O
11/3/8 CD B-NP I-DATE
0 CD I-NP I-DATE
LIPID NNP I-NP O
PANEL NNP I-NP O
: : O O
( -LRB- B-NP O
NON-FASTING NN I-NP O
) -RRB- I-NP O
: : O O
TCHOL NN B-NP O
: : O O
189 CD B-NP O
; : O O
HDL NNP B-NP O
: : O O
48 CD B-NP O
, , O O
TRIG NNP B-NP O
: : O O
154 CD B-NP O
, , O O
LDL NNP B-NP O
: : O O
110 CD B-NP O
; : O O
rechecking VBG B-NP O
today NN I-NP O
. . O O
----PAP JJ B-NP O
SMEAR NNP I-NP O
: : O O
Pt NNP B-NP O
overdue JJ I-NP O
for IN B-PP O
pap NN B-NP O
; : O O
once RB B-NP O
again RB B-ADVP O
asked VBD B-VP O
to TO B-VP O
defer VB I-VP O
given VBN I-VP O
severe JJ B-NP O
pain NN I-NP O
2/2 IN B-PP O
HS NNP B-NP O
; : O O
will MD B-VP O
continue VB I-VP O
to TO I-VP O
offer VB I-VP O
; : O O
discussed VBN B-PP O
my PRP$ B-NP O
concern NN I-NP O
regarding VBG B-VP O
continual JJ B-NP O
deferral NN I-NP O
of IN B-PP O
pap NN B-NP O
and CC O O
the DT B-NP O
risks NNS I-NP O
that IN B-PP O
this DT B-NP O
posses NNS I-NP O
. . O O
Nora NNP B-NP B-PATIENT
states NNS I-NP O
that IN B-SBAR O
she PRP B-NP O
understands VBZ B-VP O
risks NNS B-NP O
but CC O O
feels VBZ B-VP O
that IN B-SBAR O
exam NN B-NP O
would MD B-VP O
be VB I-VP O
impossible JJ B-NP O
given VBN I-NP O
pain NN I-NP O
. . O O
----MAMMOGRAM NN B-NP O
: : O O
Scheduled VBN B-VP O
on IN B-PP O
several JJ B-NP O
occasions NNS I-NP O
, , O O
but CC O O
never RB B-VP O
obtained VBD I-VP O
bc NN B-NP O
of IN B-PP O
pain NN B-NP O
. . O O
Nora NNP B-NP B-PATIENT
still RB B-ADVP O
feels VBZ B-VP O
that IN B-SBAR O
examine VB B-NP O
would MD B-VP O
be VB I-VP O
impossible JJ B-NP O
given VBN I-NP O
HS. NNP I-NP O
Will MD B-VP O
continue VB I-VP O
to TO I-VP O
discuss VB I-VP O
and CC O O
work VB B-VP O
to TO I-VP O
get VB I-VP O
treatment NN B-NP O
for IN B-PP O
her PRP$ B-NP O
HS. NNP I-NP O
Expressed NNP I-NP O
my PRP$ B-NP O
concern NN I-NP O
regarding VBG B-VP O
continual JJ B-NP O
deferral NN I-NP O
of IN B-PP O
mammogram NN B-NP O
and CC I-NP O
risk NN I-NP O
for IN B-PP O
cancer NN B-NP O
. . O O
Nora NNP B-NP B-PATIENT
states NNS I-NP O
that IN B-SBAR O
she PRP B-NP O
understands VBZ B-VP O
risk NN B-NP O
but CC O O
simply RB B-ADVP O
feels VBZ B-VP O
that IN B-SBAR O
it PRP B-NP O
would MD B-VP O
be VB I-VP O
impossible JJ B-NP O
given VBN I-NP O
level NN I-NP O
of IN B-PP O
pain NN B-NP O
. . O O
I PRP B-NP O
offered VBD B-VP O
to TO I-VP O
give VB I-VP O
her PRP$ B-NP O
pain NN I-NP O
medications NNS I-NP O
but CC O O
she PRP B-NP O
still RB B-ADVP O
does VBZ B-VP O
not RB I-VP O
feel VB I-VP O
that IN B-SBAR O
she PRP B-NP O
could MD B-VP O
undergo VB I-VP O
this DT B-NP O
test NN I-NP O
yet RB B-ADVP O
. . O O
Will MD B-VP O
continue VB I-VP O
to TO I-VP O
discuss VB I-VP O
with IN B-PP O
her PRP B-NP O
. . O O
----DV JJ B-NP O
SCREEN NNP I-NP O
: : O O
negative JJ B-NP O
today NN I-NP O
; : O O
ex-husband NN B-NP O
again RB B-ADVP O
in IN B-PP O
prison NN B-NP O
. . O O
Previous JJ O O
h/o RB B-NP O
abuse NN I-NP O
. . O O
Will MD B-VP O
continue VB I-VP O
to TO B-PP O
screen NN B-NP O
. . O O
----Ca NNP B-NP O
and CC I-NP O
VIt NNP I-NP O
D NNP I-NP O
: : O O
gave VBD B-VP O
her PRP B-NP O
PICH VB B-VP B-HOSPITAL
pt JJ B-NP O
education NN I-NP O
handout NN I-NP O
regarding VBG B-VP O
daily JJ B-NP O
requirements NNS I-NP O
----SEATBELTS NNS B-NP O
: : O O
+ NN B-NP O
use NN I-NP O
----OP JJ B-NP O
: : O O
review NN B-NP O
OP NNP I-NP O
RF NNP I-NP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
TO TO B-VP O
DO VB I-VP O
: : O O
----will JJ B-NP O
need NN I-NP O
to TO B-VP O
review VB I-VP O
previous JJ B-NP O
OPTHO NNP I-NP O
findings NNS I-NP O
; : O O
Nora NNP B-NP B-PATIENT
mentioned VBD B-VP O
that IN O O
her PRP$ B-NP O
opthomologist NN I-NP O
mentioned VBD B-VP O
something NN B-NP O
I PRP B-NP O
should MD B-VP O
know VB I-VP O
; : O O
asked VBD B-VP O
her PRP B-NP O
to TO B-VP O
get VB I-VP O
phone NN B-NP O
number NN I-NP O
so IN B-NP O
I PRP B-NP O
can MD B-VP O
call VB I-VP O
him PRP B-NP O
to TO B-VP O
find VB I-VP O
out RP B-PRT O
what WP B-NP O
she PRP B-NP O
is VBZ B-VP O
referring VBG I-VP O
to TO I-VP O
. . O O
Pt NNP B-ADJP O
to TO B-VP O
RTC NNP B-NP O
in IN B-PP O
1 CD B-NP O
mos CD I-NP O
or CC O O
sooner RB B-ADVP O
if IN B-SBAR O
needed VBN B-VP O
. . O O
Will MD B-VP O
call VB I-VP O
Nora NNP B-NP B-PATIENT
with IN B-PP O
results NNS B-NP O
of IN B-PP O
MRI. NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
presented VBN I-VP O
to TO B-NP O
and CC I-NP O
plan NN I-NP O
discussed VBN B-VP O
with IN B-PP O
attg NN B-NP O
, , O O
Dr. NNP B-NP O
Xian NNP I-NP B-DOCTOR
. . O O
Gina NNP B-NP B-DOCTOR
Kevin NNP I-NP I-DOCTOR
Irons NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
